Clin Chem Lab Med (2008) 46:6749
Why 68% of prior authorizations get denied on first submission Analysis of 2024-2025 Express Scripts prior authorization outcomes for Wegovy shows a 32% approval rate on first submission (Feldman et al., JAMA Network Open 2025)
While mild nausea, constipation, or loose stools are common when starting Wegovy, symptoms that interfere with daily activities or persist beyond a few days at each dose increase warrant medical attention
In lung cancer cells, lactate activates GPR81, which reduces intracellular cAMP and inhibits PKA activity, leading to activation of the transcriptional coactivator TAZ
In terms of formulating clinical treatment plans, if patients meet the surgical indications and do not respond well to medication, venous sinus stenting can be recommended for them